| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.38B | 20.94B | 20.10B | 18.02B | 18.61B | 18.82B |
| Gross Profit | 9.07B | 9.19B | 8.93B | 7.56B | 7.31B | 7.60B |
| EBITDA | 3.43B | 3.38B | 3.29B | 2.18B | 2.06B | 2.21B |
| Net Income | 1.75B | 1.72B | 1.72B | 786.58M | 645.42M | 47.09M |
Balance Sheet | ||||||
| Total Assets | 26.68B | 28.06B | 26.82B | 26.12B | 25.58B | 26.90B |
| Cash, Cash Equivalents and Short-Term Investments | 5.71B | 6.72B | 6.01B | 5.07B | 4.11B | 3.75B |
| Total Debt | 1.26B | 1.60B | 525.82M | 1.23B | 1.76B | 1.74B |
| Total Liabilities | 4.96B | 5.24B | 4.20B | 4.82B | 4.60B | 6.33B |
| Stockholders Equity | 21.73B | 22.82B | 22.62B | 21.30B | 20.98B | 20.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.80B | 2.34B | 2.35B | 1.40B | -2.88B |
| Operating Cash Flow | 0.00 | 2.45B | 2.76B | 2.63B | 2.41B | 289.63M |
| Investing Cash Flow | 0.00 | -770.23M | -529.65M | -541.01M | -1.17B | -2.28B |
| Financing Cash Flow | 0.00 | -1.15B | -1.30B | -1.47B | -718.34M | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥37.14B | 21.51 | ― | 2.53% | 4.16% | 1.16% | |
72 Outperform | ¥78.73B | 25.21 | ― | 2.16% | -3.65% | -47.21% | |
68 Neutral | ¥10.93B | 12.63 | ― | 4.76% | 9.96% | 54.16% | |
65 Neutral | ¥203.30B | 14.94 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥70.01B | 12.07 | ― | 3.09% | 7.43% | 47.68% | |
56 Neutral | ¥12.31B | -19.52 | ― | 5.25% | -0.83% | -210.56% |